Functionalization of silver nanocarrier with anti-tubercular drug (isoniazid) for effective antimycobacterial activity
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (78)
Show source-provided references
1. WHO, Global tuberculosis report 2023, in, World Health Organization, Geneva, Switzerland, 2023.
2. Differentiation of Mycobacterium tuberculosis complex from non-tubercular mycobacteria by nested multiplex PCR targeting IS6110, MTP40 and 32kD alpha antigen encoding gene fragments10.1186/s12879-016-1450-1 ↗
3. Multidrug resistant tuberculosis a diagnostic challenges and its conquering by nanotechnology approach: an overview
4. Current therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease10.1016/j.ijpharm.2023.123018 ↗
5. W.H.O. WHO, Implementing the WHO Stop TB Strategy: A Handbook for National Tuberculosis Control Programmes., in, Geneva, 2008.
6. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis10.1128/AAC.2.6.438 ↗
7. An evaluation of the antibacterial activities of combinations of sulfonamides, trimethoprim, dibromopropamidine, and silver nitrate compared with their uptakes by selected bacteria10.1002/jps.2600800912 ↗
8. Green synthesized silver nanoparticle-loaded liposome-based nanoarchitectonics for cancer management: in vitro drug release analysis10.3390/biomedicines11010217 ↗
9. Modulation of human macrophage responses to mycobacterium tuberculosis by silver nanoparticles of different size and surface modification10.1371/journal.pone.0143077 ↗
10. Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity10.1016/j.colsurfb.2018.12.043 ↗
11. Synergistic antibacterial effect of silver nanoparticles and extremely low-frequency pulsed magnetic fields on klebsiella pneumoniae
12. Highly efficient and selective antimicrobial isonicotinylhydrazide-coated polyoxometalate-functionalized silver nanoparticles10.1016/j.colsurfb.2019.110522 ↗
13. Five nanometer size highly positive silver nanoparticles are bactericidal targeting cell wall and adherent fimbriae expression10.1038/s41598-022-10778-9 ↗
14. Blockage of ATPase-mediated energy supply inducing metabolic disturbances in algal cells under silver nanoparticles stress10.1016/j.jes.2022.10.029 ↗
15. Silver-nanoparticle-coated biliary stent inhibits bacterial adhesion in bacterial cholangitis in swine10.1016/S1499-3872(15)60410-6 ↗
16. Rubropunctatin-silver composite nanoliposomes for eradicating Helicobacter pylori in vitro and in vivo10.1016/j.ijpharm.2023.123655 ↗
17. Synergistic antibacterial activity of silver with antibiotics correlating with the upregulation of the ROS production10.1038/s41598-018-29313-w ↗
18. Silver nanoparticles for the therapy of tuberculosis10.2147/IJN.S241183 ↗
19. Silver-containing titanium dioxide nanocapsules for combating multidrug-resistant bacteria10.2147/IJN.S231949 ↗
20. Alginate-capped silver nanoparticles as a potent anti-mycobacterial agent against mycobacterium tuberculosis10.3389/fphar.2021.746496 ↗
21. Nano-carriers for the treatment of tuberculosis
22. Advanced nanoscale drug delivery systems for bone cancer therapy10.1016/j.bbadis.2023.166739 ↗
23. Double functionalized haemocompatible silver nanoparticles control cell inflammatory homeostasis10.1371/journal.pone.0276296 ↗
24. G.-n. Feng, X.-t. Huang, X.-l. Jiang, T.-w. Deng, Q.-x. Li, J.-x. Q.-n. Li, Wu, S.-p. Li, X.-q. Sun, Y.-g. Huang, A.-p. Qin, L. Liang, J.-j. F., The antibacterial effects of supermolecular nano-carriers by combination of silver and photodynamic therapy, Front. Chem. 9 (2021) 666408.10.3389/fchem.2021.666408 ↗
25. The role of metallic nanoparticles in inhibition of mycobacterium tuberculosis and enhances phagosome maturation into the infected macrophage10.5001/omj.2020.78 ↗
26. Drug/ion co-delivery multi-functional nanocarrier to regenerate infected tissue defect10.1016/j.biomaterials.2017.07.014 ↗
27. Co-delivery of nano-silver and vancomycin via silica nanopollens for enhanced antibacterial functions10.3390/antibiotics11050685 ↗
28. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices
29. Renally excretable and size-tunable silver sulfide nanoparticles for dual-energy mammography or computed tomography10.1021/acs.chemmater.9b01750 ↗
30. Salivary excretion of renal-clearable silver nanoparticles10.1002/anie.202008416 ↗
31. Synthesis of silver nanoparticles with different shapes10.1016/j.arabjc.2014.12.014 ↗
32. Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae10.2147/IJN.S198194 ↗
33. Drug entrapment efficiency of silver nanocomposite hydrogel10.1088/1757-899X/577/1/012176 ↗
34. Superfast synthesis of stabilized silver nanoparticles using aqueous allium sativum (garlic) extract and isoniazid hydrazide conjugates: molecular docking and in-vitro characterizations
35. Spectrophotometric evidence to the formation of AuCl4-CTA complex and synthesis of gold nano-flowers with tailored surface textures10.1016/j.saa.2015.04.088 ↗
36. Spectrophotometric determination of silver with brilliant green and its application in photographic fixing solutions
37. Simultaneous determination of isoniazid and rifampicin by UV spectrophotometry
38. Micro-structural characterization of precipitation-synthesized fluorapatite nano-material by transmission electron microscopy using different sample preparation techniques10.1016/j.micron.2007.09.004 ↗
39. pH-dependent release system of isoniazid carried on nanoparticles of silica obtained from expanded perlite10.1016/j.apsusc.2019.05.317 ↗
40. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
41. Coencapsulation of hydrophobic and hydrophilic antituberculosis drugs in synergistic Brij 96 microemulsions: a biophysical characterization10.1002/jps.24469 ↗
42. P.K. V, R. J, T.F. C, T.A. K, S.K. R, S. Varughese, S. Balappa Somappa, Antibacterial and antitubercular evaluation of dihydronaphthalenone-indole hybrid analogs, Chemical biology & drug design, 90 (2017) 703-708.10.1111/cbdd.12990 ↗
43. Rapid antibacterial activity of anodized aluminum-based materials impregnated with quaternary ammonium compounds for high-touch surfaces to limit transmission of pathogenic bacteria10.1039/D1RA07159A ↗
44. Evaluation of minimum inhibitory and minimum bactericidal concentration of nano-silver base inorganic anti-microbial agent (Novaron((R))) against streptococcus mutans10.4103/0976-237X.103620 ↗
45. Antimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate Alamar Blue assay
46. T.L. Riss, R.A. Moravec, A.L. Niles, Assay guidance manual [Internet], in: Markossian S, Grossman A, Arkin M (Eds.), Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, Maryland, USA, Cell Viability Assays.
47. R. Schins, R. Duffin, D. Höhr, A. Knaapen, T. Shi, C. Weishaupt, V. Stone, K. Donaldson, P. Borm, Surface modification of quartz inhibits toxicity, particle uptake, and oxidative DNA damage in human lung epithelial cells, Chem. Res. Toxicol. 15 (2002) 1166–1173.10.1021/tx025558u ↗
48. Size- and Shape-dependent antibacterial studies of silver nanoparticles synthesized by wet chemical routes10.3390/nano6040074 ↗
49. Investigation of silver nanoparticles and plasma protein association using flow field-flow fractionation coupled with inductively coupled plasma mass spectrometry (FlFFF-ICP-MS)10.1039/C4JA00225C ↗
50. Emergence of metallicity in silver clusters in the 150 atom regime: a study of differently sized silver clusters10.1039/C4NR00679H ↗
51. Synthesis of highly monodisperse citrate-stabilized silver nanoparticles of up to 200 nm: kinetic control and catalytic properties10.1021/cm500316k ↗
52. Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii10.2147/IJN.S104166 ↗
53. Reversing the size-dependence of surface plasmon resonances10.1073/pnas.1007524107 ↗
54. Spectrophotometric determination of rifampicin and isoniazid in pharmaceutical preparations
55. The role of ligands in the chemical synthesis and applications of inorganic nanoparticles10.1021/acs.chemrev.8b00733 ↗
56. Preparation and pharmaceutical characterization of supra molecular complex of isoniazid with L(+) tartaric acid
57. FTIR, FT Raman spectra and molecular structural confirmation of isoniazid
58. A Sensitive isoniazid capped silver nanoparticles - selective colorimetric fluorescent sensor for Hg2+ ions in aqueous medium10.1007/s10895-019-02473-2 ↗
59. Studying the factors that impact the dissolution characteristic of complex drug product10.1080/10837450.2019.1647544 ↗
60. Downstream drug product processing of itraconazole nanosuspension: factors influencing drug particle size and dissolution from nanosuspension-layered beads10.1016/j.ijpharm.2017.04.012 ↗
61. Factors affecting the dissolution of indomethacin solid dispersions10.1208/s12249-017-0813-2 ↗
62. Release of molecules from nanocarriers10.1039/D3CP01855E ↗
63. Effect of rheology and poloxamers properties on release of drugs from silicon dioxide gel-filled hard gelatin capsules-a further enhancement of viability of liquid semisolid matrix technology10.1208/s12249-016-0674-0 ↗
64. Fruit derived potentially bioactive bioengineered silver nanoparticles10.2147/IJN.S330763 ↗
65. One-step fabricated keratin nanoparticles as pH and redox-responsive drug nanocarriers10.1080/09205063.2018.1519987 ↗
66. Toxicity of silver nanoparticles - nanoparticle or silver ion?10.1016/j.toxlet.2011.11.002 ↗
67. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis10.2147/DDDT.S104395 ↗
68. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis10.1016/j.meegid.2016.09.004 ↗
69. Antibacterial activity and characteristics of silver nanoparticles biosynthesized from Carduus crispus10.1038/s41598-021-00520-2 ↗
70. J. Helmlinger, C. Sengstock, C. Groß-Heitfeld, C. Mayer, T.A. Schildhauer, M. Köller, M. Epple, Silver nanoparticles with different size and shape: equal cytotoxicity, but different antibacterial effects, RSC advances, 6 (2016) 18490-18501.10.1039/C5RA27836H ↗
71. The anti-mycobacterial activity of Ag, ZnO, and Ag- ZnO nanoparticles against MDR- and XDR-mycobacterium tuberculosis10.2147/IDR.S221408 ↗
72. A preliminary study on the synergistic effect of nano Ag and anti-tuberculosis drugs on drug-resistant mycobacterium tuberculosis10.1166/jnn.2020.18597 ↗
73. Mechanism of escape from the antibacterial activity of metal-based nanoparticles in clinically relevant bacteria: a systematic review
74. Systematic review of mutations associated with isoniazid resistance points to continuing evolution and subsequent evasion of molecular detection, and potential for emergence of multidrug resistance in clinical strains of mycobacterium tuberculosis
75. An effective nano drug delivery and combination therapy for the treatment of Tuberculosis10.1038/s41598-022-13682-4 ↗
76. Volumetric, UV-Vis and FT IR studies of isoniazid in diethylsulfoxide solutions10.1007/s10953-020-01015-w ↗
77. Biochemical profiling of microbes inhibiting silver nanoparticles using symbiotic organisms
78. B. Mahitha, P.D.P.R. Borelli, G.R. Dillip, M.R. Chintala, M. Koduru, L. Manoj, S. Priyanka, K. Rao, J.S. Nannepaga, Biosynthesis, characterization and antimicrobial studies of AgNPs extract from Bacopa monniera whole plant, Digest Journal of Nanomaterials and Biostructures, Vol. 6, No 1, April - June 2011, p. 135-142 (2011) 587-594.